Sudarshan Pharma Industries Ltd — Important, 04-05-2026: Company Update

Sudarshan Pharma Industries Limited has announced its audited consolidated financial results for the quarter and financial year ended March 31, 2026. For the full year, total income grew to ₹711.77 Cr from ₹507.69 Cr, and net profit increased to ₹23.37 Cr from ₹14.97 Cr. Quarterly results also showed strong growth, with total income rising to ₹225.05 Cr from ₹162.43 Cr and net profit reaching ₹11.39 Cr from ₹7.41 Cr. This performance reflects robust operational growth and improved profitability, signaling positive momentum for shareholders.